CD38 Specific Chimeric Antigen Receptor KHYG-1 Natural Killer Cells: A Potential "Off the Shelf" Therapy for Multiple Myeloma

被引：0
|
作者：
Stikvoort, Arwen [1 ]
Sarkar, Subhashis [2 ]
Poels, Renee [1 ]
van de Donk, Niels W. C. J. [1 ]
Zweegman, Sonja [1 ]
O'Dwyer, Michael E. [2 ]
Mutis, Tuna [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands
[2] Natl Univ Ireland Galway, Sch Med, Biomed Sci, Galway, Ireland
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116403
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3261
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions
    Al Hadidi, Samer
    Zangari, Maurizio
    van Rhee, Frits
    JAMA ONCOLOGY, 2022, 8 (06) : 823 - 824
  • [42] Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma
    Cao, Bihui
    Ni, Qianqian
    Chen, Zhuxin
    Yang, Shuo
    Zhang, Xinkui
    Su, Haotao
    Zhang, Zhenfeng
    Zhao, Qi
    Zhu, Xiaolan
    Liu, Manting
    JOURNAL OF LEUKOCYTE BIOLOGY, 2024,
  • [43] Transfection with mRNA for CD19 specific chimeric antigen receptor restores natural killer cell mediated killing of CLL cells.
    Boissel, Laurent
    Betancur, Monica
    Tuncer, Hande
    Weitzman, James
    Klingemann, Hans
    BLOOD, 2007, 110 (11) : 915A - 915A
  • [44] Resistance to CD38 Antigen Targeted Therapy in Multiple Myeloma May Result from Underrecognized Chromosome 4 Gene Deletions
    Portuguese, Andrew J.
    Fang, Min
    Tuazon, Sherilyn A.
    Pont, Margot
    Qu, Xiaoyu
    Shasha, Carolyn
    Comstock, Melissa L.
    Lyons, Justina
    Cole, Gabriel
    Newell, Evan W.
    Glynn, Emily
    Soma, Lorinda
    Green, Damian J.
    BLOOD, 2023, 142
  • [45] Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
    Siegler, Elizabeth L.
    Kim, Yu Jeong
    Chen, Xianhui
    Siriwon, Natnaree
    Mac, John
    Rohrs, Jennifer A.
    Bryson, Paul D.
    Wang, Pin
    MOLECULAR THERAPY, 2017, 25 (12) : 2607 - 2619
  • [46] Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor
    Schirrmann, T
    Pecher, G
    LEUKEMIA RESEARCH, 2005, 29 (03) : 301 - 306
  • [47] The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide
    Sarkar, Subhashis
    Chauhan, Sachin K. S.
    Daly, John
    Natoni, Alessandro
    Fairfield, Heather
    Henderson, Robert
    Nolan, Emma
    Swan, Dawn
    Hu, Jinsong
    Reagan, Michaela R.
    O'Dwyer, Michael
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 421 - 434
  • [48] Targeting CD38high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells
    Nolan, Emma
    Stikvoort, Arwen
    Gurney, Mark
    Burduli, Nutsa
    Kirkham-McCarthy, Lucy
    Daly, John
    Van de Donk, Niels W. C. J.
    Mutis, Tuna
    Sarkar, Subhashis
    O'Dwyer, Michael E.
    BLOOD, 2019, 134
  • [49] γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
    Pont, Margot J.
    Hill, Tyler
    Cole, Gabriel O.
    Abbott, Joe J.
    Kelliher, Jessica
    Salter, Alexander I.
    Hudecek, Michael
    Comstock, Melissa L.
    Rajan, Anusha
    Patel, Bharvin K. R.
    Voutsinas, Jenna M.
    Wu, Qian
    Liu, Lingfeng
    Cowan, Andrew J.
    Wood, Brent L.
    Green, Damian J.
    Riddell, Stanley R.
    BLOOD, 2019, 134 (19) : 1585 - 1597
  • [50] The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide
    Subhashis Sarkar
    Sachin K. S. Chauhan
    John Daly
    Alessandro Natoni
    Heather Fairfield
    Robert Henderson
    Emma Nolan
    Dawn Swan
    Jinsong Hu
    Michaela R. Reagan
    Michael O’Dwyer
    Cancer Immunology, Immunotherapy, 2020, 69 : 421 - 434
12345